Darshan N. Banker
Vadodara, GJ, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Ticagrelor vs Prasugrel in Patients With Diabetes and Multivessel Coronary Artery Disease: The TUXEDO-2 Randomized Clinical Trial.
Journal: JAMA cardiology
Published: February 11, 2026
Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial.
Journal: Journal of the American College of Cardiology
Published: January 26, 2026
Rationale and design of the TUXEDO-2 India study: Ultra-Thin strUt Supraflex Cruz versus XiencE in a Diabetic pOpulation with multi-vessel disease-2.
Journal: American heart journal
Published: July 23, 2022
Fractional flow reserve [FFR] guided stenting of left main coronary artery in acute coronary syndrome: A single centre experience.
Journal: Indian heart journal
Published: February 12, 2021
One-year outcomes of a BioMime™ Sirolimus-Eluting Coronary Stent System with a biodegradable polymer in all-comers coronary artery disease patients: The meriT-3 study.
Journal: Indian heart journal
Published: August 25, 2016
Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes.
Journal: The New England journal of medicine
Published: October 15, 2015
Clinical performance of biodegradable polymer-coated sirolimus-eluting stents in unselected real-world population with coronary artery disease: results from the multicenter CORE Registry.
Journal: Minerva cardioangiologica
Published: April 25, 2015
Impact of catalytic iron on mortality in patients with acute coronary syndrome exposed to iodinated radiocontrast-The Iscom Study.
Journal: American heart journal
Published: September 10, 2012
Systemic exposure of sirolimus after coronary stent implantation in patients with de novo coronary lesions: Supralimus-Core® pharmacokinetic study.
Journal: Indian heart journal
Published: June 06, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026